Evidence map›Paper›PMID 26526658›Full record

ArticleCurrent fungal infection reports2012

Recent Taxonomic Developments with

Mary E Brandt, Shawn R Lockhart

Abstract read
In one paragraph

Article in Current fungal infection reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 95 citations in OpenAlex.

  1. Xylitol: A Promising Sweetener Produced byIndian journal of microbiology · 2026
    Review
  2. Review
  3. Article
  4. Post-endoscopic neurosurgicalFrontiers in medicine · 2026
    Article
  5. Review
  6. Impact of Biofilm Formation by VaginalJournal of fungi (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Current global status of Candida auris an emerging multidrug-resistant fungal pathogen: bibliometric analysis and network visualization.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Journal of fungi (Basel, Switzerland) · 2023
    Article
  19. Iranian journal of microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Mary E BrandtMycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road; Mailstop G-11, Atlanta, GA 30333, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road; Mailstop G-11, Atlanta, GA 30333, USA.
AID Atlanta · USCenters for Disease Control and Prevention · UG

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Increases in susceptible patient populations and advances in identification methods have resulted in the continued recognition of novel yeasts as agents of human infection. Most of these agents are members of the well-recognized genera

Indexed as

Antifungal resistanceCandida speciesCryptococcus speciesEmerging fungal infectionsNon-albicans CandidaTrichosporon speciesYeast infection

Identifiers

PMID26526658
PMCPMC4626447
OpenAlexW2116911851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.